From the Chief Executive
As the mining boom sputters out, Australia is taking a long-overdue look at ways to improve its competitiveness in a cut-throat global marketplace.
The global business environment is changing rapidly. The economic rise and technological advances of many Asian nations may open up new markets for Australia, but it is also introducing new competitors.
News and Updates
Medicines Australia Chairman Dr Martin Cross today welcomed the release of the Government’s Industry Innovation and Competitiveness Agenda and the announcement of five industry growth centres.
“Australia is uniquely placed to harness our competitive advantages, particularly in the medical technologies, pharmaceuticals and advanced manufacturing sectors,” Dr Cross said.
A proposed campaign to stop doctors learning about new treatments from medicines companies is misguided and potentially dangerous for patients, the Medicines Australia Chairman Dr Martin Cross has warned.
A small group of physicians, joined by academics and special interest groups, is reportedly planning to encourage blocking all contact between doctors and medicines companies in the mistaken belief that this will improve prescribing practice and cut costs.
A study claiming to find additional prescription medicine savings appears to have again refused to properly take account of the additional ongoing savings accruing through the current price disclosure policy.
Medicines Australia Chairman Dr Martin Cross has rejected Professor Philip Clarke’s claim that the Government is overpaying $400 million for medicines.
“The current price disclosure policy is working as it is delivering significant savings to government and patients.
Today’s release of the 2013-14 Final Budget Outcome shows the Government has yet again spent less than they anticipated on the Pharmaceutical Benefits Scheme (PBS).
“The Final Budget Outcome released today has seen yet another write down in PBS expenditure, a write down of $168 million, just in the four months since the 2014 Federal Budget, and the fifth consecutive time the Government has had to revise its figures downwards,” said Medicines Australia Chairman Dr Martin Cross.